Pancreatic Cancer Research

ResearcherAalborg University HospitalActive in the last 2 years

Louise S. Rasmussen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6042-779X; OpenAlex author ID A5020416356. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 4 papers · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 13

  1. The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. Co-author DOI 10.1158/1078-0432.ccr-25-0758↗
  2. Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2025.1568386↗
  3. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic c… Co-author DOI 10.1186/s12885-023-11035-6↗
  4. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic c… Co-author DOI 10.21203/rs.3.rs-2955930/v1↗
  5. Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer. First author DOI 10.1080/0284186x.2021.2012252↗
  6. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.ejca.2020.10.038↗
  7. Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival i… Co-author DOI 10.1016/j.ejca.2021.09.009↗
  8. Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry Study. Co-author DOI 10.1097/mpa.0000000000001833↗
  9. Regional and age differences in specialised palliative care for patients with pancreatic cancer. Co-author DOI 10.1186/s12904-021-00870-8↗
  10. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study. Co-author DOI 10.1016/j.ejca.2020.01.015↗
  11. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer. Co-author DOI 10.1111/ecc.13219↗
  12. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0672↗
  13. The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study. Co-author DOI 10.1080/0284186x.2019.1581374↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Inna Markovna Chen · 10 shared papers, 2020–2025 · strength 1.43
  2. Per Pfeiffer · 11 shared papers, 2019–2025 · strength 1.34
  3. Julia Sidenius Johansen · 9 shared papers, 2020–2025 · strength 1.29
  4. Morten Bækbo Ladekarl · 7 shared papers, 2019–2025 · strength 0.98
  5. Britta Weber · 5 shared papers, 2020–2023 · strength 0.67
  6. Carsten Palnæs Hansen · 6 shared papers, 2019–2025 · strength 0.66
  7. Astrid Zedlitz Johansen · 5 shared papers, 2020–2025 · strength 0.59
  8. Sönke Detlefsen · 4 shared papers, 2019–2023 · strength 0.49
  9. Claus Wilki Fristrup · 4 shared papers, 2019–2022 · strength 0.42
  10. Lars Henrik Jensen · 2 shared papers, 2025 · strength 0.42
  11. Sture Falkmer · 4 shared papers, 2020–2021 · strength 0.41
  12. Jon Kroll Bjerregaard · 4 shared papers, 2020–2021 · strength 0.40
  13. Gabor Istvan Liposits · 2 shared papers, 2023 · strength 0.32
  14. Stine Brændegaard Winther · 2 shared papers, 2023 · strength 0.32
  15. Frank Viborg Mortensen · 3 shared papers, 2019–2022 · strength 0.31
  16. Mette Nissen · 2 shared papers, 2020–2021 · strength 0.24
  17. Karen‐Lise Garm Spindler · 1 shared paper, 2025 · strength 0.23
  18. Sidsel C. Lindgaard · 1 shared paper, 2025 · strength 0.23
  19. Mette M. Steiniche · 1 shared paper, 2025 · strength 0.23
  20. Benjamin Emil Stubbe · 1 shared paper, 2025 · strength 0.19
  21. Stine Dam Henriksen · 1 shared paper, 2025 · strength 0.19
  22. Ole Thorlacius‐Ussing · 1 shared paper, 2025 · strength 0.19
  23. Michael Bau Mortensen · 2 shared papers, 2019–2020 · strength 0.17
  24. Susy Shim · 1 shared paper, 2023 · strength 0.16
  25. Susy Shim · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.